NOTICE: In light of the COVID-19 pandemic, Dalton continues to follow public health guidelines in implementing protocols to ensure the safety and health of our team, customers, and community. We will continue to create and maintain a safe environment so that our dedicated team can continue their important work.

Integrated Drug Discovery, Drug Development and Manufacturing

Dalton Pharma Services is a leading cGMP contract service provider of integrated drug discovery, development and manufacturing services to the pharmaceutical and biotechnology industries. We are FDA Inspected and Health Canada approved, and bring over 30 years of experience to every project. We deliver fully integrated solutions with an emphasis on speed, flexibility and quality. We are experts in Custom Synthesis, cGMP API Manufacturing, Formulation Development, API Process DevelopmentSterile Filling Services and Accelerated Stability Services.

We understand your project needs and will deliver:

♦   Highest Quality
♦   Shorter Timelines
♦   Minimized Cost
♦   Regulatory Compliance
♦   Keeping you Informed
Dalton is excited to be part of the global pharmaceutical development community as we come together in innovative ways to develop novel medicines faster by providing the following services:
Diamond Therapeutics Hires Industry Veteran David Brown, PhD, to Further Advance Formulation of Psilocybin by Dalton Pharma
Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.
Dalton is a Health Canada approved, and FDA inspected, GMP contract provider of integrated chemistry, drug development and manufacturing services to the pharmaceutical and biotechnology industries.
Dalton Pharma Services offers consultation services and customized testing capabilities for determining extractables and leachables on container closure systems.
Dalton Pharma Services, a leading North-American contract drug manufacturing organization is proud to have been recognized for the 5th straight year as a Great Place to Work® in Canada.
Dalton Pharma Services is pleased to announce a partnership with the University of Saskatchewan’s Vaccine and Infectious Disease Organization–International Vaccine Centre (VIDO-InterVac) in their effort to develop a vaccine for COVID-19.
Dalton Pharma Services is pleased to receive the license amendment from Health Canada under Cannabis regulations enabling transfer of finished cGMP cannabis products to licensed dealers.